

Is Amicar still in shortage in 2026? Get the latest update on Aminocaproic Acid availability, pricing, and what you can do to find it.
If you're a patient who depends on Amicar (Aminocaproic Acid) and you've been struggling to fill your prescription, you're probably wondering: is the shortage over yet?
The short answer is that the situation has improved since 2023, but Aminocaproic Acid availability remains uneven across the country. Some pharmacies have it in stock; others don't. Some formulations are available; others have been permanently discontinued. Here's the full picture as of early 2026.
The Amicar supply problem didn't happen overnight. Here's how we got here:
The FDA and the American Society of Health-System Pharmacists (ASHP) have been tracking aminocaproic acid oral products on their drug shortage lists.
It depends on which formulation you need:
Generic Aminocaproic Acid tablets are currently in production by multiple manufacturers. Most patients should be able to obtain tablets, though not every pharmacy keeps them on the shelf. If your pharmacy doesn't stock it, they can typically order it within 1 to 2 business days.
The liquid form has been more difficult to find. With Akorn and Vistapharm both discontinuing their versions, the number of suppliers is limited. If you or your child needs the liquid form, you may need to work with a compounding pharmacy or switch to tablets if appropriate.
The injectable form is primarily used in hospital settings. Hospital supply has generally been more stable, though individual institutions may experience periodic shortages depending on their distributor.
Even though the initial crisis has eased, several ongoing factors keep Amicar harder to find than most medications:
Cost is another barrier for many patients. Here's what you can expect:
If cost is a concern, read our full guide on how to save money on Amicar in 2026, including coupon cards, patient assistance programs, and other strategies.
While no brand-new antifibrinolytic drugs have entered the market, there are options worth discussing with your doctor:
Tranexamic Acid (Lysteda, Cyklokapron) works through the same mechanism as Amicar but is about 10 times more potent. It's more widely available and stocked at most pharmacies. If you've been unable to fill your Amicar prescription, this is the most direct substitute. See our full comparison in alternatives to Amicar.
If you need the oral solution form and can't find a commercially manufactured version, a compounding pharmacy can prepare Aminocaproic Acid liquid for you. Your doctor will need to write a prescription specifically for the compounded version. Ask your doctor or pharmacist for a referral to a reputable compounding pharmacy.
Some hospital-based pharmacies maintain stock of Aminocaproic Acid because it's used in surgical settings. If you're affiliated with a hospital system, check whether their outpatient pharmacy can fill your prescription.
Here are the most effective steps you can take today:
For a complete walkthrough, see our guide on how to find Amicar in stock near you.
The Amicar shortage has improved since 2023, but it's not fully resolved. Patients who need Aminocaproic Acid — especially the oral solution — may still face challenges. The best strategy is to stay proactive: use Medfinder to check availability, refill early, explore independent pharmacies, and keep an open conversation with your doctor about alternatives.
We'll continue updating this article as the situation changes. For more information about Amicar, explore these related articles:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.